Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Anaptysbio (ANAB) Long-Term Debt Repayments: 2018-2020

Historic Long-Term Debt Repayments for Anaptysbio (ANAB) over the last 2 years, with Mar 2020 value amounting to $1.4 million.

  • Anaptysbio's Long-Term Debt Repayments fell 26.67% to $1.4 million in Q1 2020 from the same period last year, while for Mar 2020 it was $7.0 million, marking a year-over-year decrease of 6.67%. This contributed to the annual value of $1.4 million for FY2020, which is 81.67% down from last year.
  • Latest data reveals that Anaptysbio reported Long-Term Debt Repayments of $1.4 million as of Q1 2020, which was down 26.67% from $1.9 million recorded in Q4 2019.
  • In the past 5 years, Anaptysbio's Long-Term Debt Repayments registered a high of $1.9 million during Q2 2018, and its lowest value of $1.2 million during Q1 2018.
  • In the last 3 years, Anaptysbio's Long-Term Debt Repayments had a median value of $1.9 million in 2019 and averaged $1.8 million.
  • In the last 5 years, Anaptysbio's Long-Term Debt Repayments spiked by 50.00% in 2019 and then dropped by 26.67% in 2020.
  • Over the past 3 years, Anaptysbio's Long-Term Debt Repayments (Quarterly) stood at $1.9 million in 2018, then remained steady at $1.9 million in 2019, then dropped by 26.67% to $1.4 million in 2020.
  • Its Long-Term Debt Repayments stands at $1.4 million for Q1 2020, versus $1.9 million for Q4 2019 and $1.9 million for Q3 2019.